nLIGHT, Inc. — FY2022 Form 10-K Summary
Reporting period: Fiscal year ended December 31, 2022. This filing provides annual results; standalone fourth-quarter financial results are not clearly provided in the supplied text.
Business context
nLIGHT designs and manufactures high-power semiconductor and fiber lasers, fiber amplifiers, and directed-energy products. Its two segments are Laser Products and Advanced Development; it serves Industrial, Microfabrication, and Aerospace and Defense markets.
Key financial metrics
| Metric | FY2022 | FY2021 |
|---|---|---|
| Revenue | $242.1 million | $270.1 million |
| Gross profit / margin | $50.8 million / 21.0% | $77.3 million / 28.6% |
| Operating loss | $55.1 million | $30.2 million |
| Net loss | $54.6 million | $29.7 million |
| Net loss per diluted share | $1.23 | $0.70 |
| Operating cash flow | $(14.5) million | $(7.4) million |
| Capital expenditures | $21.4 million | $19.3 million |
| Cash, cash equivalents and marketable securities at year-end | $108.2 million | $146.5 million in cash and cash equivalents |
- Revenue fell 10.4%. Laser Products revenue declined 6.6% to $192.7 million; Advanced Development revenue fell 22.8% to $49.4 million.
- Revenue by market: Industrial $91.1 million (down 3.9%); Microfabrication $62.8 million (down 10.9%); Aerospace and Defense $88.2 million (down 16.0%).
- Gross margin deterioration reflected product mix, lower factory utilization, higher labor, materials and freight costs, and inventory charges.
- Year-end inventory was $67.6 million, down from $73.7 million. Current assets were $230.8 million and current liabilities $34.5 million.
- No borrowings were outstanding under the $40 million revolving credit facility, which expires in September 2024; the company reported compliance with covenants.
Material changes and unusual items
- China revenue declined 61.6% to $21.3 million; revenue outside China increased. The two-month Shanghai facility shutdown in Q2 affected production and sales.
- Fourth-quarter restructuring charges totaled $3.9 million, including $1.3 million in employee termination costs and $2.6 million for abandoned production-capacity equipment projects. Discontinued product lines also drove inventory charges.
- Backlog fell to $80.4 million from $115.9 million; the company expected to fulfill year-end 2022 backlog within 12 months, while cautioning that orders may be canceled or deferred.
- Top ten customers represented approximately 63% of revenue. The U.S. Government accounted for 17% of FY2022 revenue.
- The company reported a pending patent ownership lawsuit filed by Lumentum in March 2022. Management stated loss was not probable and reasonably estimable; no loss contingency was recorded.
Outlook, commentary and risks
Management stated existing liquidity should be sufficient for working capital and capital expenditures for at least the next 12 months. The filing gives no numerical revenue, earnings, or margin guidance. Management anticipates continued investment in research and development and product development, while noting that inflation-related wage, material, and shipping cost increases may continue.
- Key risks include competitive pricing and declining selling prices, cyclical industrial and semiconductor-equipment demand, customer concentration, and recurring losses.
- Supply-chain constraints and reliance on single- or limited-source suppliers may affect production. Export controls and trade tensions could restrict China-related sales or sourcing.
- The company identified its excess and obsolete inventory estimate as a critical audit matter. KPMG issued unqualified opinions on the financial statements and internal control over financial reporting.
- Management cited a full valuation allowance against U.S. and China deferred tax assets and risks to the use of tax-loss carryforwards.
Important facts for investors to verify
- Whether demand and backlog stabilize, particularly in China and Aerospace and Defense, and whether revenue declines reverse.
- Whether gross margins recover as factory utilization, product mix, input costs, and inventory charges change.
- Cash use, capital spending, and liquidity relative to the $47.3 million in 2023 purchase commitments and other obligations.
- Progress on reducing customer concentration and the operational resilience of the Shanghai facility and constrained supply sources.
- Developments in the Lumentum patent litigation, export-control requirements, and the company’s ability to use tax attributes.